Similasan Nasen-Wundsalbe, Nasencreme

7680549600270 CH-54960 Nasencreme
Similasan Nasen-Wundsalbe, Nasencreme
Similasan Nasen-Wundsalbe, Nasencreme
Similasan Nasen-Wundsalbe, Nasencreme
1 / 3
google

Article details

Package size
2 x 5
Selling units
2
Measure
g
Galenic form
Nasencreme
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/02/2024
Patient information leaflet
Français
12/02/2024
Patient information leaflet
Italien
12/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
200.0 MG Substance HBESI
(N/A)
100.0 MG Substance HBESI
(N/A)
50.0 MG Substance HBESI
(N/A)
200.0 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
54960
Drug name
Similasan Nasen-Wundsalbe, Nasencreme
Galenic form
NASC
Authorization status
Z
Dispensing category
D
First authorization
04/01/2001
Authorization expiration date
31/12/9999
IT Number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei trockener und gereizter Nasenschleimhaut

Package details

Description (FR)
SIMILASAN Pommade nasale vulnéraire 2 tb 5 g
Description (DE)
SIMILASAN Nasen-Wundsalbe 2 Tb 5 g
Market launch
04/01/2001
Narcotic (BTM)
No

Other package sizes (1)

None
None None
GTIN: None
Not in V1